Metraipolis › archive › dc_da2d4cd931eb

Myostatin inhibition with orally administered Lactobacillus casei expressing a modified human myostatin protein: functional benefits and translational… — Europe PMC PMID:41607848

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41607848
DOI: 10.3389/fneur.2025.1693484
License (as archived): solo-consultazione
Archived: 2026-11-06T20:35:59.841Z
SHA-256 of the archived text: 0ac83a4edffe88f2f5925a90f0ee5fc24e32766c5366484240a825466ca33745
Stable URL of this page: https://metraipolis.com/documento/dc_da2d4cd931eb

How to cite

Myostatin inhibition with orally administered Lactobacillus casei expressing a modified human myostatin protein: functional benefits and translational… — Europe PMC PMID:41607848 — Europe PMC (en), https://europepmc.org/article/MED/41607848 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da2d4cd931eb (Metraipolis archive dc_da2d4cd931eb, sha256 0ac83a4edffe88f2f5925a90f0ee5fc24e32766c5366484240a825466ca33745)

BibTeX

@misc{dcda2d4cd931eb,
  title = {Myostatin inhibition with orally administered Lactobacillus casei expressing a modified human myostatin protein: functional benefits and translational… — Europe PMC PMID:41607848},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41607848},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da2d4cd931eb; sha256 0ac83a4edffe88f2f5925a90f0ee5fc24e32766c5366484240a825466ca33745},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41607848. Agents can read the archived copy with the MCP tool read_document.